DANIEL G. WELCH - 24 May 2024 Form 4 Insider Report for Nuvation Bio Inc. (NUVB)

Role
Director
Signature
/s/ Ron A. Metzger, Attorney-in-Fact
Issuer symbol
NUVB
Transactions as of
24 May 2024
Net transactions value
+$1,111,633
Form type
4
Filing time
29 May 2024, 16:38:34 UTC
Previous filing
17 May 2024
Next filing
20 Jun 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NUVB Class A Common Stock Options Exercise $510,173 +293,203 $1.74 293,203 24 May 2024 Direct
transaction NUVB Class A Common Stock Options Exercise $601,460 +366,744 +125% $1.64 659,947 24 May 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NUVB Stock Option (Right to Buy) Options Exercise $0 -293,203 -94% $0.000000 19,547 24 May 2024 Class A Common Stock 293,203 $1.74 Direct F1
transaction NUVB Stock Option (Right to Buy) Options Exercise $0 -366,744 -100% $0.000000* 0 24 May 2024 Class A Common Stock 366,744 $1.64 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Option vests in 48 equal monthly installments from July 22, 2020.
F2 Option is fully vested and exercisable.